Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations
- PMID: 20069569
- PMCID: PMC3122883
- DOI: 10.1002/jcb.22461
Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations
Abstract
Epigenetic remodeling is a hallmark of cancer, with the frequent acquisition of de novo DNA methylation in CpG islands. However, the functional relevance of de novo DNA methylation in cancer is less well defined. To begin to address this issue in B-cells, we used BeadArray assays to survey the methylation status of over 1,500 cancer-related CpG loci in two molecular subtypes of diffuse large B-cell lymphoma (ABC-DLBCL and GCB-DLBCL) and cognate normal B-cell populations. We identified 81 loci that showed frequent de novo DNA methylation in GCB-DLBCL and 67 loci that showed frequent de novo DNA methylation in ABC-DLBCL. These de novo methylated CpG loci included reported targets of polycomb repressive complexes (PRC) in stem cells. All candidate loci in GCB-DLBCL are proximal to genes that are poorly expressed or silent in purified normal germinal center (GC) B-cells. This is consistent with the hypothesis that de novo DNA methylation in cancer is more frequently involved in the maintenance rather than the initiation of gene silencing (de novo repression). This suggests that epigenetic switching occurs during tumorigenesis with de novo DNA methylation locking in gene silencing normally mediated by transcriptional repressors. Furthermore, we propose that similar to de novo genetic mutations, the majority of de novo DNA methylation events observed in tumors are passengers not causally involved in tumorigenesis.
(c) 2010 Wiley-Liss, Inc.
Figures


Similar articles
-
DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status.Leukemia. 2008 May;22(5):1035-43. doi: 10.1038/leu.2008.18. Epub 2008 Feb 21. Leukemia. 2008. PMID: 18288132 Free PMC article.
-
DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.Sci Rep. 2017 Sep 14;7(1):11591. doi: 10.1038/s41598-017-11724-w. Sci Rep. 2017. PMID: 28912427 Free PMC article.
-
Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma.Leuk Lymphoma. 2015;56(8):2429-38. doi: 10.3109/10428194.2014.994181. Epub 2015 Jan 21. Leuk Lymphoma. 2015. PMID: 25487076
-
The significance of FOXP1 in diffuse large B-cell lymphoma.Leuk Lymphoma. 2017 May;58(5):1037-1051. doi: 10.1080/10428194.2016.1228932. Epub 2016 Sep 27. Leuk Lymphoma. 2017. PMID: 27678023 Review.
-
Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?Oncologist. 2012;17(12):1562-73. doi: 10.1634/theoncologist.2012-0218. Epub 2012 Oct 18. Oncologist. 2012. PMID: 23086691 Free PMC article. Review.
Cited by
-
Statistical approaches for the analysis of DNA methylation microarray data.Hum Genet. 2011 Jun;129(6):585-95. doi: 10.1007/s00439-011-0993-x. Epub 2011 Apr 26. Hum Genet. 2011. PMID: 21519831 Free PMC article. Review.
-
The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis.Stem Cell Res Ther. 2012 Oct 4;3(5):39. doi: 10.1186/scrt130. Stem Cell Res Ther. 2012. PMID: 23036268 Free PMC article.
-
Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.Stem Cell Res Ther. 2015 Aug 29;6:158. doi: 10.1186/s13287-015-0149-3. Stem Cell Res Ther. 2015. PMID: 26319495 Free PMC article.
-
Identification of novel candidate genes involved in mineralization of dental enamel by genome-wide transcript profiling.J Cell Physiol. 2012 May;227(5):2264-75. doi: 10.1002/jcp.22965. J Cell Physiol. 2012. PMID: 21809343 Free PMC article.
-
Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma.Epigenetics. 2014 Mar;9(3):428-36. doi: 10.4161/epi.27554. Epub 2013 Dec 20. Epigenetics. 2014. PMID: 24362313 Free PMC article.
References
-
- Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Jr., Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–511. - PubMed
-
- Allman D, Jain A, Dent A, Maile RR, Selvaggi T, Kehry MR, Staudt LM. BCL-6 expression during B-cell activation. Blood. 1996;87:5257–5268. - PubMed
-
- Bachman KE, Park BH, Rhee I, Rajagopalan H, Herman JG, Baylin SB, Kinzler KW, Vogelstein B. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell. 2003;3:89–95. - PubMed
-
- Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R, Powell J, Wilson WH, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Campo E, Rosenwald A. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood. 2005;106:3183–3190. - PMC - PubMed
-
- Bibikova M, Fan JB. GoldenGate assay for DNA methylation profiling. Methods Mol Biol. 2009;507:149–163. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- RR10600-01/RR/NCRR NIH HHS/United States
- U01 CA114778/CA/NCI NIH HHS/United States
- CA84967/CA/NCI NIH HHS/United States
- CA36727/CA/NCI NIH HHS/United States
- C06 CA062528/CA/NCI NIH HHS/United States
- R21 CA152497/CA/NCI NIH HHS/United States
- R01 GM072447/GM/NIGMS NIH HHS/United States
- RR14514-01/RR/NCRR NIH HHS/United States
- P30 CA036727/CA/NCI NIH HHS/United States
- CA62528-01/CA/NCI NIH HHS/United States
- R01 GM072477/GM/NIGMS NIH HHS/United States
- P50 HG002790/HG/NHGRI NIH HHS/United States
- R01 CA137060/CA/NCI NIH HHS/United States
- P50-HG002790/HG/NHGRI NIH HHS/United States
- U01 CA084967/CA/NCI NIH HHS/United States
- C06 RR014514/RR/NCRR NIH HHS/United States
- CA114778/CA/NCI NIH HHS/United States
- GM072447/GM/NIGMS NIH HHS/United States
- R01 CA139032/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous